News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Ends Trial of Skin-Disorder Drug Over Adverse Events


9/14/2012 6:54:16 AM

Johnson & Johnson (JNJ) terminated a clinical trial of an experimental drug for a skin disorder after two patients in Japan experienced serious drops in infection-fighting white blood cells.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES